Register Login
Register to leave comments
  • News bot June 30, 2026, 11:23 p.m.

    🔍 Jamil Khurram (Executive)

    Company: GALECTIN THERAPEUTICS INC (GALT)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 52,037
    • Total shares sold: 104,074

    Detailed Transactions and Holdings:

    • Acquired 2,037 shares of Common Stock at $2.2 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 2,037.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,037 shares of Common Stock at $5.0 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 2,533 shares of Common Stock at $2.5 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 2,533.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,533 shares of Common Stock at $5.0 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 47,467 shares of Common Stock at $2.5 per share (Direct)
      Date: 2026-06-29 | Code: M | equity_swap_involved: false | shares_owned_after: 47,467.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 47,467 shares of Common Stock at $5.04 per share (Direct)
      Date: 2026-06-29 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 2,037 shares of Stock option (right to buy) at $2.2 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2034-03-20 | Exercise: 2025-03-11 | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 2,533 shares of Stock Option (right to buy) at $2.5 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2034-08-01 | Exercise: 2025-04-30 | equity_swap_involved: false | shares_owned_after: 47,467.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 47,467 shares of Stock Option (right to buy) at $2.5 per share (Derivative)
      Date: 2026-06-29 | Code: M | Expires: 2034-08-01 | Exercise: 2025-07-31 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 2, 2026, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on May 15, 2026
    • F2: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.01. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F3: The options vested at a rate of one-third or 50,000 options on each of March 11, 2025, March 11, 2026 and March 11, 2027.
    • F4: The options vested at a rate of twenty five percent or 25,000 options on each of October 31, 2024, January 31, 2025, April 30, 2025 and July 31, 2025.
    • F5: The shares were sold in multiple transactions at prices ranging from $5.00 to $5.13. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Search

News categories